Bone Marrow Examination in Small Cell Lung Cancer
Authors: FRED R. HIRSCH
Journal: Annals of Internal Medicine (1987)

Letters and Corrections1 June 1987Bone Marrow Examination in Small Cell Lung CancerFRED R. HIRSCH, M.D., KELL ØSTERLIND, M.D., PAUL E. G. KRISTJANSEN, M.D., HEINE H. HANSEN, M.D.FRED R. HIRSCH, M.D.Search for more papers by this author, KELL ØSTERLIND, M.D.Search for more papers by this author, PAUL E. G. KRISTJANSEN, M.D.Search for more papers by this author, HEINE H. HANSEN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-106-6-913_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: The question whether examination of bone marrow is necessary for patients with small cell lung cancer has recently been raised by Campling and associates (1) and has also been the subject of an editorial (2). Our previous articles about this issue were cited (3, 4), which prompts us to comment on the article by Campling and associates.The authors conclude that the pretreatment bone marrow examination does not have any clinically significant prognostic implication. When comparing patients with extensive disease with and without bone marrow involvement the authors foundpvalues of 0.036 (Wilcoxon-Gehan) 0.075 (log rank),...References1. CAMPLINGQUIRTDE BOERFELDSHEPHERDEVANS BIGRFW. Is bone-marrow examination in small-cell lung cancer really necessary? Ann Intern Med. 1986;105:508-12. LinkGoogle Scholar2. Is bone-marrow sampling necessary in patients with small-cell lung cancer [Editorial]? Lancet. 1987;1:83. MedlineGoogle Scholar3. HIRSCHHANSEN FH. Bone marrow involvement in small cell anaplastic carcinoma of the lung: prognostic and therapeutic aspects. Cancer. 1980;46:206-11. CrossrefMedlineGoogle Scholar4. HANSENDOMBERNOWSKYHIRSCH HPF. Staging procedures and prognostic features in small cell anaplastic bronchogenic carcinoma. Semin Oncol. 1978;5:280-7. MedlineGoogle Scholar5. ØSTERLINDHANSENHANSEN KHM. Long-term disease-free survival in small cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol. 1986;4:1307-13. CrossrefMedlineGoogle Scholar6. ØSTERLINDHANSENHANSENDOMBERNOWSKY KHMP. Mortality and morbidity in long-term surviving patients treated with chemotherapy with or without irradiation for small cell lung cancer. J Clin Oncol. 1986;4:1044-52. CrossrefMedlineGoogle Scholar7. ØSTERLINDHIRSCHPEDERSEN KFA. Serum lactate dehydrogenase and bone-marrow metastases in small cell carcinoma of the lung. N Engl J Med. 1985;313:759-60. CrossrefMedlineGoogle Scholar8. ØSTERLINDIHDEETTINGER KDD. Staging and prognostic factors in small cell carcinoma of the lung. Cancer Treat Rep. 1983;67:3-9. MedlineGoogle Scholar9. HIRSCHHANSENHAINAU FHB. Bilateral bone-marrow examination in small cell anaplastic carcinoma of the lung. Acta Pathol Microbiol Immunol Scand [A]. 1979;87:59-62. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Finsen Institute Copenhagen Denmark PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 June 1987Volume 106, Issue 6Page: 913-913KeywordsBone marrowSmall cell lung cancer Issue Published: 1 June 1987 PDF DownloadLoading ...